Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Walking Performance: Correlation between Energy Cost of Walking and Walking Participation. New Statistical Approach Concerning Outcome Measurement.
Oligodendroglia and neurotrophic factors in neurodegeneration.
Disease-Modifying Therapy of Pediatric Multiple Sclerosis.
Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine.
Sex-related differences of cAMP-specific PDE4B3 mRNA in oligodendrocytes following systemic inflammation.
Time to first relapse as an endpoint in multiple sclerosis clinical trials.
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
Voiding dysfunction in patients with neuromyelitis optica spectrum disorders.
Glia in the pathogenesis of neurodegenerative diseases.
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.
Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.
Clinical data and regulatory issues of biosimilar products.
Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar rats.
Emerging roles of system [Formula: see text] antiporter and its inhibition in CNS disorders.
A high throughput flow gradient LC-MS/MS method for simultaneous determination of fingolimod, fampridine and prednisone in rat plasma, application to in vivo perfusion study.
Bouncing back again, and again: a qualitative study of resilience in people with multiple sclerosis.
[Microglia in pathophysiology of neuroimmunological disorders].
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
Exercise in the community for people with multiple sclerosis -- a follow-up of people with minimal gait impairment.
Cost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature.
Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta.
A nexus between lipids and multiple sclerosis?
A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS.

Pages